We are live on ! Find out more
GMAB icon

Genmab
GMAB

193 hedge funds and large institutions have $1.43B invested in Genmab in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 21

32% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 60

24% more capital invested

Capital invested by funds: $1.15B → $1.43B (+$276M)

13.43% more ownership

Funds ownership: 54.07% → 67.5% (+13%)

7% more funds holding

Funds holding: 180 → 193 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
193
Holders Change
+13
Holders Change %
+7.22%
% of All Funds
3.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
36
Increased
79
Reduced
60
Closed
21
Calls
$7.94M
Puts
–
Net Calls
+$7.94M
Net Calls Change
+$3.56M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$203M
2
First Trust Advisors
First Trust Advisors
Illinois
+$45.3M
3
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$33.4M
4
CCM
CAAS Capital Management
New York
+$12.3M
5
Goldman Sachs
Goldman Sachs
New York
+$8.03M

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$15M
2
Macquarie Group
Macquarie Group
Australia
-$9.87M
3
BlackRock
BlackRock
New York
-$6.14M
4
CFM
Capricorn Fund Managers
United Kingdom
-$4.8M
5
HJGA
Hardman Johnston Global Advisors
Connecticut
-$3.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$8.1M – – –
SSA
27
Schonfeld Strategic Advisors
New York
$7.93M +$1.27M +36,090 +17%
ACM
28
Aquilo Capital Management
California
$7.87M +$1.05M +30,000 +14%
Natixis Advisors
29
Natixis Advisors
Massachusetts
$7.62M +$3.83M +109,103 +85%
RJA
30
Raymond James & Associates
Florida
$6.91M -$1.18M -33,703 -14%
BAMCO Inc
31
BAMCO Inc
New York
$6.19M -$520K -14,800 -7%
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$6.01M -$654K -18,639 -9%
JP Morgan Chase
33
JP Morgan Chase
New York
$5.78M +$223K +6,357 +4%
WJWM
34
Williams Jones Wealth Management
New York
$5.52M -$413K -11,748 -6%
Lord, Abbett & Co
35
Lord, Abbett & Co
New Jersey
$5.46M -$1.79M -51,113 -23%
FLAM
36
First Light Asset Management
Minnesota
$5.2M +$29.6K +842 +0.5%
F
37
Folketrygdfondet
Norway
$5.05M – – –
CSS
38
Cubist Systematic Strategies
Connecticut
$4.79M +$3.06M +87,153 +141%
OAM
39
Oppenheimer Asset Management
New York
$4.36M -$153K -4,359 -3%
Optiver Holding
40
Optiver Holding
Netherlands
$4.3M +$3.36M +95,826 +251%
TIP
41
Torray Investment Partners
Maryland
$4.22M -$9.76K -278 -0.2%
HL
42
Harding Loevner
New Jersey
$4.15M -$37.3K -1,061 -0.8%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$4.08M -$302K -8,588 -6%
CS
44
Candriam SCA
Luxembourg
$3.94M +$73.3K +2,087 +2%
Millennium Management
45
Millennium Management
New York
$3.91M +$4.27M +121,638 New
CCB
46
Cutter & Co Brokerage
Missouri
$3.77M -$93K -2,650 -2%
Kayne Anderson Rudnick Investment Management
47
Kayne Anderson Rudnick Investment Management
California
$3.63M -$82.8K -2,359 -2%
SF
48
Synovus Financial
Georgia
$3.01M -$20.1K -573 -0.6%
US Bancorp
49
US Bancorp
Minnesota
$2.97M +$1.18M +33,531 +57%
SEI Investments
50
SEI Investments
Pennsylvania
$2.75M +$458K +13,038 +18%
1
2
3 4 5

GMAB Hedge Fund Activity: Q3 2022 in Review

193 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2022, worth a combined $1.43B — up 24% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new GMAB positions and 21 closed out — a net gain of 15 holders — while 79 added to existing stakes and 60 trimmed.

The largest buyer was AllianceBernstein, opening a new position worth an estimated $203M. The largest seller was Artisan Partners, cutting an estimated $15M.

  • 193 institutional investors held Genmab (GMAB) as of Q3 2022, up from 180 in Q2 2022.
  • Funds reported $1.43B of Genmab stock for Q3 2022, up 24% quarter-over-quarter.
  • 36 funds opened new Genmab positions in Q3 2022 and 21 closed out, a net change of +15 holders.
  • The largest Genmab buyer in Q3 2022 was AllianceBernstein, an estimated $203M added.
  • The largest Genmab seller in Q3 2022 was Artisan Partners, an estimated $15M sold.

Based on aggregated 13F filings for Q3 2022.